03/13/2026
Mohammed Yamin, BS; Micaela Tobin, BA; Tricia Raquepo, BA; John B. Park, PharmD; Helen Xun, MD; Eric Zhu, PharmD; Maria J. Escobar-Domingo, MD; James E. Fanning, BS; Amy Chen, BS; Haobo Ma, MD; Bernard T. Lee, MD, MBA, MPH; Ryan P. Cauley, MD, MPH
Autologous breast reconstruction in patients with heparin-induced thrombocytopenia requires alternative anticoagulation strategies and multidisciplinary planning to mitigate thrombotic risk while maintaining flap viability during...
Autologous breast reconstruction in patients with heparin-induced thrombocytopenia requires alternative anticoagulation strategies and multidisciplinary planning to mitigate thrombotic risk while maintaining flap viability during...
Autologous breast reconstruction...